Prostate Cancer Clinical Trial

Prospective Evaluation of a Commercially Available Hydrogel Spacer

Summary

Dosimetry efficacy evaluation of the hydrogel spacer

View Full Description

Full Description

Single arm study for evaluation of dosimetry following use of a commercially available hydrogel spacer implanted in 20 males undergoing radiotherapy to treat prostate cancer. Study will utilize pre and post gel insertion CT images to determine the endpoints.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Males
At lease 18 years of age
Undergoing external beam or brachy radiation therapy with a hydrogel spacer

Exclusion Criteria:

Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension

Study is for people with:

Prostate Cancer

Estimated Enrollment:

20

Study ID:

NCT05323747

Recruitment Status:

Completed

Sponsor:

BioProtect

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Western Radiation Oncology
Campbell California, 95008, United States
Northern Nevada Radiation Oncology
Reno Nevada, 89521, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

20

Study ID:

NCT05323747

Recruitment Status:

Completed

Sponsor:


BioProtect

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider